
PendoPharma Profile last edited on: 3/23/2022
Specialty prescription products plus large/established line of OTC and BTC products.
Year Founded
1983Last Involved Year
N/AKey People / Management
Jean-Fran�ois Lemieux -- National Sales Director
Sean A MacDonald -- Director, Business Development
Frank Puglisi -- Senior Director, Head of Business Development
Elise V�zina -- Vice-President & Division Head
Sean A MacDonald -- Director, Business Development
Frank Puglisi -- Senior Director, Head of Business Development
Elise V�zina -- Vice-President & Division Head
Location Information
6111 Royalmount Avenue
Montreal Quebec, CN H4P 2T4
Montreal Quebec, CN H4P 2T4
(514) 340-5045 |
www.pendopharm.com |
Public Profile
PENDOPHARM, Division of Pharmascience Inc. Established in 1983 and privately-owned, With a strong focus on specialty Mmedicines PENDOPHARM is a rapidly growing, independent business focused on commercializing a portfolio of specialty prescription products and an established line of OTC/BTC products. Strategically committed to growth, PENDOPHARM is actively engaged in licensing, developing and marketing late-stage prescription products as well as consumer brands. Partnership is a key component of the firms growth strategy with a business model focused on developing long-term alliances that create synergistic value for both parties by aligning the firms corporate capabilities, operations and resources to facilitate collaborations. The firm has the capability to provide expert regulatory filing, drug safety and medical information, logistics and distribution, customer service, manufacturing, sales/marketing, pricing, market access, and all other aspects of commercialization.
Pharmascience Inc. is the largest pharmaceutical company in Quebec, with a highly skilled workforce of 1,300 people. Pharmascience commercializes nearly 300 products in over 1,000 formats, including generic, branded prescription, OTC and BTC products. In Canada alone, more than 21 million prescriptions a year are filled with Pharmascience products. Additionally, Pharmascience has a significant international presence, with 25% of its sales coming from 60 countries. Operationally, Pharmascience is fully integrated and controls all aspects of production, from manufacturing to commercialization. It has state-of-the-art laboratory, manufacturing and research & development facilities, with the capability of manufacturing capsules, tablets, suppositories, liquids and suspensions. Financially, Pharmascience is well capitalized and has consistently experienced double-digit growth, with current sales of Cnd$700 million.
Extent of SBIR involvement
Synopsis: Techseeker Business Condition
Headquartered
CanadaEmployment
1,300Revenue
$700.0MPublic/Private
Privately HeldStock Info
----Received SBIR $$
NoTechseeker firm in the news
There are no news available.